Novadip Biosciences

Mont-saint-guibert, Belgium

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

$23.4M raised

Nov 2022

Series B

Biotechnology Health Care Medical Therapeutics

Top Investors

New Science Ventures Vives Louvain Technology Fund Investsud Fund+CR-CP Life Science Fund

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Novadip Biosciences

How much funding has Novadip Biosciences raised?

Novadip Biosciences has raised $23.4M in total funding. The most recent round was Series B. The last funding was announced in November 2022.

Who are Novadip Biosciences's investors?

Novadip Biosciences's investors include New Science Ventures, Vives Louvain Technology Fund, Investsud, Fund+, CR-CP Life Science Fund.

Where is Novadip Biosciences headquartered?

Novadip Biosciences is headquartered in Mont-saint-guibert, Belgium.

What does Novadip Biosciences do?

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

What stage is Novadip Biosciences at?

Novadip Biosciences is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 3, 2022.

MLA

"Novadip Biosciences — Funding & Investors." VCBacked, November 3, 2022, https://www.vcbacked.co/company/novadip-biosciences. Accessed July 4, 2026.

APA

VCBacked. (2022). Novadip Biosciences — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/novadip-biosciences

Wikipedia (cite web)

{{cite web |title=Novadip Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/novadip-biosciences |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 3, 2022.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K